Sign in
CompletedPhase 4

A Randomized Trial of GVS Alone vs. Propranolol

Key facts

Who runs it
Taipei Veterans General Hospital, Taiwan
Where
Taiwan2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
120 people enrolled
Started
Apr 2010
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • propranolol
Record updated
18 August 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • patients with live cirrhosis and/or hepatoma
  • Aged 18 to 80, who had endoscopy-Proven EV(-)GV(+)or EV<GV

Who cannot take part

  • Patients had previous endoscopic, surgical treatment or Transjugular Intrahepatic Portosystemic Shunt
  • Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Design a randomized trial to compare the effect of endoscopic cyanoacrylate injection obliteration versus non-selective beta-blocker in the primary prevention of gastric variceal bleeding.

The 2 groups in the trial

  • CyanoacrylateNo study treatment, for comparison

    Endoscopic Cyanoacrylate Injection treatment of primary prevention GVB

  • PropranololExisting treatment, for comparison

    Propranolol is used for primary prevention of GVB

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Primary Prevention of Gastric Variceal Bleeding : Endoscopic Treatment Versus Non-selective Beta-blocker
Record updated
18 August 2026